من نحن

The Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) is inviting proposals for operational research to integrate female genital schistosomiasis (FGS) into sexual, reproductive, and primary health systems in endemic countries. FGS is a chronic and often overlooked manifestation of schistosome infections that disproportionately affects women and girls in sub-Saharan Africa, leading to stigma, misdiagnosis, and confusion with sexually transmitted infections. With the World Health Organization estimating that 56 million women and girls are affected, this call seeks projects that advance sustainable integration of FGS diagnosis, treatment, and care into existing health services such as cervical cancer and HPV screening, HIV prevention, STI management, fertility, and family planning. Eligible activities include evaluating integrated in-service training programs, conducting cost and efficiency analyses, piloting delivery systems for donated praziquantel, ensuring sustainable drug availability, and fostering effective community engagement strategies. Proposals should highlight innovation, national engagement, local leadership, sustainability, scalability, cost-effectiveness, and alignment with WHO disease-specific targets. Funding of up to USD 175,000 per project is available, with all research activities to be completed by 1 December 2027, and three to five projects are expected to be supported under this call.

معايير القبول

Applications must be led by programs based in endemic countries and demonstrate alignment with national or sub-national health system priorities. Each proposal must include a co-investigator from the sexual and reproductive health, family planning, cervical cancer/HPV, or HIV field, a letter of support from a non-NTD Ministry of Health program, a Theory of Change, and a detailed project budget using the required NTD-SC template. Incomplete applications will not be considered. Proposals will be evaluated on scientific merit, feasibility, innovation, sustainability, scalability, cost-effectiveness, and adherence to WHO guidelines and national priorities.

Post Date: August 20, 2026